Skip to content

Assessment of Implants Placed in Consolidated Graft With Different Bone Drills.

ASSESSMENT OF DENTAL IMPLANTS PLACED IN MANDIBULAR CONSOLIDATED ILIAC-CREST BONE GRAFTS USING DENSAH BURS VERSUS THE STANDARD DRILLS (A Randomized Controlled Trial)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06477874
Enrollment
12
Registered
2024-06-27
Start date
2024-06-09
Completion date
2025-04-01
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Graft; Mechanical Complications, Implant Complication

Keywords

Bone graft, Iliac crest, Implant stability

Brief summary

The anterior iliac crest is a popular source of bone harvest. However, when fused to the intramembranous jaw bones, it yields low-density bones that qualitatively and quantitatively endanger the fixture's stability. In 1994, Summers first documented using the bone-condensing approach to improve the primary stability of dental implants. This study aims to determine whether osseodensifying the consolidated mandibular bone grafts will improve implant stability and marginal bone loss

Interventions

implants placed in consolidated bone grafts

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Patients of both sexes with an age range of 18-55 years. 2. Patients subjected to a successful iliac crest mandibular bone graft after segmental mandibular resection. 3. A minimal ridge height of ten millimeters and a ridge width of seven millimeters. 4. Healthy soft tissue coverage, with a reasonable interaction space.

Exclusion criteria

1. Clinical or radiographic signs of graft infection, rejection, or massive resorption. 2. The previous exposure to radiotherapy or chemotherapy. 3. Any systemic disease that would affect bone healing or implant osseointegration.

Design outcomes

Primary

MeasureTime frameDescription
Radiographic bone loss6 months osseointegration periodCalibration of the amplitude of vertical bone loss

Secondary

MeasureTime frameDescription
Implant stability6 months osseointegration periodCalibration of primary and secondary implant stability quotient

Countries

Egypt

Contacts

Primary ContactMaged Seleet, PHD
magedseleet@hotmail.com01000367625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026